Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» GlaxoSmithKline: FDA requires more data to approve experimental drug for nausea, vomiting
GlaxoSmithKline: FDA requires more data to approve experimental drug for nausea, vomiting
GlaxoSmithKline: FDA requires more data to approve experimental drug for nausea, vomiting
Submitted by
admin
on June 24, 2009 - 7:50am
Source:
Yahoo/AP
News Tags:
GSK
nausea
FDA
casopitant
Headline:
GlaxoSmithKline: FDA requires more data to approve experimental drug for nausea, vomiting
Do Not Allow Advertisers to Use My Personal information
